AFP DEPARTMENT COLLECTION

Medicine by the Numbers

From The NNT Group, these provide short, concise, evidence-based ratings of therapies, diagnostic tests, and risk assessments commonly used in family medicine. These rating are based on patient-important benefits and harms.

Dec 1, 2017 Issue
Topical Capsaicin for Treatment of Chronic Neuropathic Pain in Adults


Nov 1, 2017 Issue
Statins in Persons at Low Risk of Cardiovascular Disease
Despite the small reductions in nonfatal heart attacks and strokes, statins were not associated with a reduction in serious illness overall


Oct 1, 2017 Issue
Prolonged Dual Antiplatelet Therapy After MI Reduces Major Adverse Cardiac Events
In patients who are stable one year post-MI, prolonged use of dual antiplatelet therapy may be an effective treatment to decrease major cardiac events and cardiovascular mortality.


Sep 1, 2017 Issue
Varenicline for Smoking Cessation
Do the benefits outweigh the harms of using varenicline (Chantix) for smoking cessation? Read more to find out.


Aug 1, 2017 Issue
Antipsychotics for Fibromyalgia in Adults
Quetiapine may be considered for a limited period (less than 12 weeks) to improve pain, sleep, and depression in fibromyalgia, while considering the potential for weight gain.


Jul 1, 2017 Issue
Tenofovir for Prevention of HIV Infection
The benefits are greater than the harm in using tenofovir for HIV prevention, but cost-effectiveness and personal preferences are critical.


Jun 1, 2017 Issue
Efficacy of Direct-Acting Antivirals Compared with Older Agents for Hepatitis C
Although they help patients achieve sustained viralogic response, expensive direct-acting antivirals have yet to show that they can succeed in meeting top-priority treatment goals.


May 1, 2017 Issue
Oral NSAIDs for Perineal Pain in the Early Postpartum Period
Oral nonsteroidal anti-inflammatory drugs were able to adequately relieve perineal pain for many postpartum women at four hours and longer.


Apr 1, 2017 Issue
Vitamin E in Pregnancy
Vitamin E supplementation in pregnant women does not show any benefit among the most patient-important outcomes.


Mar 1, 2017 Issue
Buprenorphine Maintenance vs. Placebo for Opioid Dependence
Buprenorphine causes lower physical dependence, milder withdrawal symptoms, and is less likely to cause an overdose than methadone in the treatment of opioid dependence.


Pages: 1 2 3 4 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now